高级搜索

不同PSA水平的国人首次前列腺穿刺活检所需穿刺针数的研究

徐叶青, 郭剑明, 朱延军, 杨念钦, 王一惟, 王国民

徐叶青, 郭剑明, 朱延军, 杨念钦, 王一惟, 王国民. 不同PSA水平的国人首次前列腺穿刺活检所需穿刺针数的研究[J]. 肿瘤防治研究, 2014, 41(02): 124-127. DOI: 10.3971/j.issn.1000-8578.2014.02.007
引用本文: 徐叶青, 郭剑明, 朱延军, 杨念钦, 王一惟, 王国民. 不同PSA水平的国人首次前列腺穿刺活检所需穿刺针数的研究[J]. 肿瘤防治研究, 2014, 41(02): 124-127. DOI: 10.3971/j.issn.1000-8578.2014.02.007
shu
XU Yeqing, GUO Jianming, ZHU Yanjun, YANG Nianqin, WANG Yiwei, WANG Guomin. Comparison of Puncture Methods for Transrectal Ultrasound-guided Prostate Biopsy at Various PSA Levels[J]. Cancer Research on Prevention and Treatment, 2014, 41(02): 124-127. DOI: 10.3971/j.issn.1000-8578.2014.02.007
Citation: XU Yeqing, GUO Jianming, ZHU Yanjun, YANG Nianqin, WANG Yiwei, WANG Guomin. Comparison of Puncture Methods for Transrectal Ultrasound-guided Prostate Biopsy at Various PSA Levels[J]. Cancer Research on Prevention and Treatment, 2014, 41(02): 124-127. DOI: 10.3971/j.issn.1000-8578.2014.02.007
shu

不同PSA水平的国人首次前列腺穿刺活检所需穿刺针数的研究

  • 200032 上海，复旦大学附属中山医院泌尿外科

详细信息
    作者简介:

    徐叶青（1979-），男，本科，主管技师，主要从事前列腺癌的基础和临床研究

    通讯作者:

    郭剑明，E-mail:guo.jianming@zs-hospital.sh.cn

  • 中图分类号: R737.25

Comparison of Puncture Methods for Transrectal Ultrasound-guided Prostate Biopsy at Various PSA Levels

  • Department of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

摘要

    摘要
  • 摘要: 目的 比较不同PSA水平患者采用6点法和12点法的前列腺活检阳性率，探讨针对不同的患者人群设计国人合理的首次前列腺穿刺点数。 方法 通过研究首次接受直肠超声引导经会阴前列腺穿刺的425例患者，在PSA的不同水平段，比较6点法和12点法的阳性率的差异，以及阳性患者穿刺活检Gleason评分与前列腺癌根治术后病理标本Gleason评分之间的差异。 结果 425例患者中6点法穿刺224例，12点法201例。PSA＞20 ng/ml的患者6点法与12点法的阳性率分别为85.3%、77.5%（P＞0.05）；PSA10~20 ng/ml患者6点法和12点法的阳性率分别为33.8%、39.1%（P＞0.05）。两者的12点法比6点法没有更高的阳性率。PSA≤10 ng/ml患者6点法和12点法的阳性率分别为24.1%、45.8%（P ＜0.05），12点法比6点法阳性率显著提高。结论 对于国人首次行前列腺穿刺，若PSA＞20 ng/ml推荐行6点法穿刺；PSA≤10 ng/ml推荐12点法穿刺，而PSA在10~20 ng/ml则两种穿刺方法均可以选用。

     

    Abstract: Objective To study whether patients benefit more from the 12-point method than the 6-point method in prostate biopsy, and recommend suitable point method for treatment. Methods The first time transrectal ultrasound-guided prostate biopsy was performed in 425 cases, among which 224 cases underwent the 6-point puncture method and the other 201 cases underwent the 12-point puncture method. In this study we compared the positive rate of different methods at various PSA levels and the variation of Gleason score before and after surgery. Results In patients with PSA>20ng/ml, the positive rate of 6- and 12-point method were 85.3% and 77.5% (P>0.05) respectively. In patients with 10ng/ml＜PSA≤20 ng/ml, the positive rate of 6- and 12-point method were 33.8% and 39.1% (P>0.05). The 12-point method didn't bring a higher positive rate than the 6-point method. In the group of PSA≤10 ng/ml, the positive rate of 6- and 12-point method was 24.1% and 45.8%, respectively (P<0.05). The 12-point method brought a statistically higher positive rate than the 6-point method. Conclusion For patients with PSA>20 ng/ml, 6-point method is suffi cient for diagnosis and treatment guidance. For patients with PSA≤10 ng/ml, 12-point method is recommended. For patients with 10≤PSA<20 ng/ml, both 6- and 12-point methods are applicable.

     

    • HTML全文
    • 参考文献(13)
  • [1] Zhang FB, Shao Q, Du Y, et al. Ultrasound-guided transperinea1 24 -core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA＜20 μg/ L[J] Zhonghua Nan Ke Xue Za Zhi,2012,18(4):306-9. [张峰波， 邵强，杜源，等. 经会阴前列腺24针饱和穿刺活检与14针活检 在PSA＜20 μg/L患者中筛检前列腺癌的对比性研究[J]. 中华男 科学杂志,2012,18(4):306-9.]
    [2] Eichler K, Hempel S, Wilby J, et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review[J]. J Urol,2006,175(5):1605-12.
    [3] Na YQ, Ye ZQ, Sun G, et al. Guideline to diagnosis and treatment of urological diseases China[M]. Beijing: People's Health Publishing House, 2011:51. [那彦群,叶章群,孙光,等. 中国 泌尿外科疾病诊断治疗指南手册[M]. 北京:人民卫生出版 社,2011:51.]
    [4] Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate[J]. J Urol,1989,142(1):66-70.
    [5] Scattoni V, Raber M, Abdollah F, et al. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy[J]. Eur Urol,2010,57(1):1-8.
    [6] Thompson IM, Ankerst DP, Chi C, et al. Operating characteristics of prostate-specifi c antigen in men with an initial PSA level of 3.0 ng/ml or lower[J]. JAMA,2005,294(1):66-70.
    [7] Yoon DK, Park JY, Yoon S, et al. Can the prostate risk calculator based on Western population be applied to Asian population?[J]. Prostate,2012,72(7):721-9.
    [8] Wu J, Ma YZ, Chen Z, et al. Comparison of 6 o'clock and 12 o'clock position prostate biopsy cores for detection of prostate cancer:a retrospective analysis[J]. Shanghai Yi Xue,2011,34(7):532-5.[ 吴 嘉,马扬之,陈忠,等. 6点与12点前列腺穿刺活组织检查诊断前 列腺癌的回顾性比较分析[J]. 上海医学,2011,34(7):532-5.]
    [9] Delongchamps NB, de la Roza G, Jones R, et al. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer[J]. BJU Int,2009,103(1):49-54.
    [10] Novara G, Boscolo-Berto R, Lamon C, et al. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate[J]. BJU Int,2010,105(9):1242-6.
    [11] Zaytoun OM, Moussa AS, Gao T, et al. Offi ce based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population[J]. J Urol,2011,186(3):850-4.
    [12] Emiliozzi P, Maymone S, Paterno A, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy[J]. J Urol,2004,172(6 Pt 1):2224-6.
    [13] King CR, McNeal JE, Gill H, et al. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients[J]. Int J Radiat Oncol Biol Phys,2004,59(2):386-91.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  1513
  • HTML全文浏览量:  296
  • PDF下载量:  1053
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-09-01
  • 修回日期:  2013-09-29
  • 刊出日期:  2014-02-24

目录

摘要
HTML全文
    参考文献(13)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    下载中心

    友情链接

    联系我们

    地址：武汉市洪山区卓刀泉南路116号（430079）

    电话：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    邮件订阅 RSS
    总访问量：12443633 今日访问：20856

    版权所有 © 《肿瘤防治研究》编辑部 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    本系统由北京仁和汇智信息技术有限公司开发  百度统计

    x 关闭 永久关闭